Simulations Plus Inc
Închisă
SectorSănătate
18.42
Rezumat
Modificarea prețului
24h
Minim
18.42
Maxim
18.42
Venit | -960K 3.6M |
|---|---|
Vânzări | -2.4M 22M |
P/E Medie Sector | 46.075 56.597 |
EPS | 0.3 |
Marjă de profit | 16.335 |
Angajați | 212 |
EBITDA | -6.3M 1.1M |
Capitalizare de piață | 1.6M 373M |
|---|---|
Deschiderea anterioară | 18.42 |
Închiderea anterioară | 18.42 |
Sentimentul știrilor
By Acuity
17%
83%
17 / 339 Clasament în Healthcare
Simulations Plus Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
Simulations Plus Inc Așteptări
Sentiment
By Acuity
17 / 339 Clasament în Sănătate
Sentimentul știrilor
Evidențe foarte puternice de creștere
Volatilitate
Sub medie
Volumul știrilor (RCV)
Sub medie
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
